510(k) Report

510(k) · Cleared

Cleared

Tandem-R Ostase Immunoradiometric Assay

K930810510(k) TraditionalCleared Jan 11, 1994328-day reviewClass II21 CFR 862.1050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Hybritech, Inc. · CIN Electrophoretic Separation, Alkaline Phosphatase Isoenzymes

Cleared on Jan 11, 1994 after a 328-day review. FDA has not posted a summary or statement for it, so its predicates are not known. 5 later devices descend from it.

Decided
Jan 11, 1994
Review
328 days
Class
Class II
Product code
CIN
Recalls
None
Predicates
0

5 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 1996: 1 descendant cleared1997: 1 descendant cleared2000: 1 descendant cleared2020: 1 descendant cleared2024: 1 descendant cleared1990200020102020
  1. This deviceK930810 Tandem-R Ostase Immunoradiometric AssayHybritech, Inc. · 1994
  2. Descendant · cites it directly · 4 of its ownK961573 Tandem-R Ostase Immunoradiometric AssayHybritech, Inc. · 1996
  3. Descendant · 2 generations on · 1 of its ownK994278 Access Ostase Immunoenzymetric AssayBeckman Coulter, Inc. · 2000 · Recalled
  4. Descendant · 2 generations on · 1 of its ownK972666 Tandem-MP Ostase Immunoenzymetric AssayHybritech, Inc. · 1997
  5. Descendant · 3 generations on · 0 of its ownK232904 Access OstaseBeckman Coulter · 2024
  6. Descendant · 3 generations on · 0 of its ownK200475 IDS-iSYS Ostase BAPImmunodiagnostic Systems, Ltd. · 2020

Most influential descendants

Showing 5 of 5 · See all
  • K961573Tandem-R Ostase Immunoradiometric AssayHybritech, Inc. · 1996 · cites it directly4descendants
  • K994278Access Ostase Immunoenzymetric AssayBeckman Coulter, Inc. · 2000 · 2 generations on1descendant
  • K972666Tandem-MP Ostase Immunoenzymetric AssayHybritech, Inc. · 1997 · 2 generations on1descendant
  • K232904Access OstaseBeckman Coulter · 2024 · 3 generations on0descendants
  • K200475IDS-iSYS Ostase BAPImmunodiagnostic Systems, Ltd. · 2020 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K930810Tandem-R Ostase Immunoradiometric AssayHybritech, Inc.1994—
+1K961573Tandem-R Ostase Immunoradiometric AssayHybritech, Inc.1996—
+2K994278Access Ostase Immunoenzymetric AssayBeckman Coulter, Inc.20006
+2K972666Tandem-MP Ostase Immunoenzymetric AssayHybritech, Inc.1997—
+3K232904Access OstaseBeckman Coulter2024—
+3K200475IDS-iSYS Ostase BAPImmunodiagnostic Systems, Ltd.2020—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
199610
199710
200010
202010
202410
FIG. 1 — Lineage of K930810, 1994–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in CIN? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new CIN device

  1. #1 K232904 Access Ostasescore 7.8 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against?

FDA has not posted a summary or statement for it, so its predicates are not known.

What descends from it? (5)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K961573Tandem-R Ostase Immunoradiometric AssayHybritech, Inc.19964

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K961573 (Hybritech, Inc., 1996) has gone furthest, with 4 descendants of its own.

How does its category compare?

All CIN devices

CIN Electrophoretic Separation, Alkaline Phosphatase Isoenzymes: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · CIN

1in 2024

2020: 12024: 1
2007high 1 (2020) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · CIN

Too few CIN 510(k)s in any year since 2007 to give a median.

Recalls per year · CIN

3in 2012

2011: 32012: 3
2007high 3 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · CIN

1in 2012

2011: 22012: 1
2007high 2 (2011) · low 0 (2007)2025

MAUDE reports naming product code CIN, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—32
20120—31
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20201—00
20210—00
20220—00
20230—00
20241—00
20250—00
20260—0—
Cite this page

510(k) Report. “K930810: Tandem-R Ostase Immunoradiometric Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K930810

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026